Буковинский Государственный Медицинский Университет Мз Украины
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Буковинский Государственный Медицинский Университет Мз УкраиныfiledCriticalБуковинский Государственный Медицинский Университет Мз Украины
Priority to UAU201301305UpriorityCriticalpatent/UA81414U/en
Publication of UA81414UpublicationCriticalpatent/UA81414U/en
A method for treating depressive and anxiety disorders in the patients with ischemic heart disease comprises medicamentous treatment including selective inhibitor of the serotonin reverse uptake Sertralin hydrochloride and non-benzodiazeoin anxiolytic Afobasol. At the same time, miliotherapy, family therapy, cognitive behavioral psychotherapy and autogenic training are used.
UAU201301305U2013-02-042013-02-04Method for treating depressive and anxiety disorders in patients with ischemic heart disease
UA81414U
(en)